Reliability and Validity of the French Version of the Virtual Reality Sickness Questionnaire

NCT ID: NCT06466590

Last Updated: 2025-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-05-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter, controlled, non-randomized interventional clinical study, with minimal risks and constraints, aimed at verifying the reliability of the French version of the VRSQ questionnaire (VRSQ-F) and the validity of the VRSQ-F score by comparing it with the SSQ score.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Virtual Reality Cyber Sickness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All participants will perform 4 exercises in virtual reality with HMD (Head Mounted Display). Then, they will use the VRSQ-F instrument under study on 2 times separated by 15 minutes. The primary objective is to assess the reliability and validity of this instrument through repeated measures and comparison to SSQ
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single Group

Participants will be asked to use the measurement instrument VRSQ-F on two separate occasions under identical conditions to assess its test-retest reliability and asked to use the SSQ for validity. Each session will involve completing the measurement protocol as specified.

Group Type EXPERIMENTAL

Use of Measurement Instrument

Intervention Type DIAGNOSTIC_TEST

Participants will complete the measurement procedure twice, with sessions scheduled one week apart, using the same instrument under standardized conditions. The results from both sessions will be compared to assess the instrument's consistency and accuracy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use of Measurement Instrument

Participants will complete the measurement procedure twice, with sessions scheduled one week apart, using the same instrument under standardized conditions. The results from both sessions will be compared to assess the instrument's consistency and accuracy

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For Healthy people :

* Men or women aged 18 to 65
* Person affiliated to a social security scheme
* Healthy person with no particular medical condition
* Having given their consent to participate in the research

For patients :

* Men or women aged 18 to 65
* Persons affiliated to a social security scheme
* People undergoing regular rehabilitation, walking or in a wheelchair, who can use a virtual reality solution as part of their care.
* Having given their consent to take part in the research

Exclusion Criteria

* Vestibular and cardiac pathologies, and major visual disorders not compatible with virtual reality rehabilitation
* Cognitive and language disorders
* Persons under legal protection
* Pregnant women
* MSSQ greater than 15
* People suffering from photosensitive epilepsy
* Persons under the influence of medication that may impair drugs or alcohol
* Participant with an implanted medical device that may be affected by radio waves emitted by compatible third-party equipment (e.g. : Pacemaker)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pôle Saint Hélier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilie LEBLONG

Role: PRINCIPAL_INVESTIGATOR

Pôle Saint Hélier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de Rééducation Fonctionnelle Neurologique PROPARA

Montpellier, , France

Site Status

Pôle Saint-Hélier

Rennes, , France

Site Status

Fondation Ildys

Roscoff, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A02468-37

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Empathy and Virtual Reality (VR)
NCT07314788 NOT_YET_RECRUITING NA